Shanliang Sun
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Dexamethasone activates anti-tumor immunity in multiple myeloma by dismantling the GR-PPP1CB complex to restore STING/IRF3 signaling.
Journal: Journal for immunotherapy of cancer
Published: June 08, 2026
Reprogrammed Propionate Metabolism Alters Redox-Dependent Aldosterone Production.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: June 04, 2026
Pharmacologic Management of Sleep Bruxism in Adults: A Systematic Review and Meta-Analysis of Polysomnographic Outcomes.
Journal: Journal of oral rehabilitation
Published: April 15, 2026
DEAF1 confers resistance to adriamycin-induced apoptosis and pyroptosis in multiple myeloma.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: October 22, 2025
SAE1 promotes tumor cell malignancy via SUMOylation and liquid-liquid phase separation facilitated nuclear export of p27.
Journal: Acta pharmaceutica Sinica. B
Published: August 21, 2024
PNPO-Mediated Oxidation of DVL3 Promotes Multiple Myeloma Malignancy and Osteoclastogenesis by Activating the Wnt/β-Catenin Pathway.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 08, 2024
KLSD: a kinase database focused on ligand similarity and diversity.
Journal: Frontiers in pharmacology
Published: March 14, 2024
Non-coding RNAs as therapeutic targets in cancer and its clinical application.
Journal: Journal of pharmaceutical analysis
Published: October 27, 2023
Unraveling a Combined Inactivation Mechanism of Cytochrome P450s by Genipin, the Major Reactive Aglycone Derived from Gardeniae Fructus.
Journal: Chemical research in toxicology
Published: August 25, 2023
Correction: AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 19, 2023
GART Functions as a Novel Methyltransferase in the RUVBL1/β-Catenin Signaling Pathway to Promote Tumor Stemness in Colorectal Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 24, 2023
Mechanistic Study of Icaritin-Induced Inactivation of Cytochrome P450 2C9.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: December 31, 2022
Last Updated: 09/26/2026